Bcl-2 distribution in neuroepithelial tumors: an immunohistochemical study D. SchifferP. CavallaL. Chiadò-Piat Laboratory Investigation Pages: 101 - 109
Infrequency of p53 gene mutations in ependymomas Karen L. FinkElisabeth J. RushingPerry D. Nisen Laboratory Investigation Pages: 111 - 115
Immunohistochemical evaluation of erbB-2 and p53 protein expression in benign and atypical human meningiomas Bruce S. ChozickDeborah L. BenzilPaul W. Finch Laboratory Investigation Pages: 117 - 126
Reversion of phenotype of endothelial cells in brain tissue around glioblastomas Rui VazNuno BorgesIsabel Azevedo Laboratory Investigation Pages: 127 - 132
Adoptive immunotherapy using lymphokine-activated killer (LAK) cells and interleukin-2 for recurrent malignant primary brain tumors Suresh K. SankhlaJ. S. NadkarniS. N. Bhagwati Clinical Study Pages: 133 - 140
Intra arterial chemotherapy with ACNU and radiotherapy in inoperable malignant gliomas L. ChauveincM. T. Sola-MartinezJ. Chiras Clinical Study Pages: 141 - 147
Phase II study of prolonged oral therapy with etoposide (VP16) for patients with recurrent malignant glioma Dorcas FultonRaul UrtasunPeter Forsyth Clinical Study Pages: 149 - 155
Interstitial chemotherapy with mitoxantrone in recurrent malignant glioma: preliminary data Amerigo BoiardiAndrea SalmaggiAntonio Silvani Clinical Study Pages: 157 - 162
Association of 82 Rubidium and 11C-methionine uptake in brain tumors measured by positron emission tomography Ulrich RoelckeErnst RadüKlaus Leonhard Leenders Clinical Study Pages: 163 - 172
Low-grade pure and mixed cerebral astrocytomas treated in the CT scan era J. P. BaharyJ. G. VillemureJ. Hazel Clinical Study Pages: 173 - 177
Autologous tumor cell vaccination combined with adoptive cellular immunotherapy in patients with Grade III/IV astrocytoma Frank P. HolladayTeresa Heitz-TurnerGary W. Wood Clinical Study Pages: 179 - 189
